e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Community-acquired pneumonia: clinical approaches
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A novel approach in the treatment of aspiration pneumonia and primary lung abscess
S. Ott, M. Allewelt, G. Korfmann, A. Kureishi, J. Lorenz, H. Lode (Berlin, Wuppertal, Luedenscheid, Germany)
Source:
Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Session:
Community-acquired pneumonia: clinical approaches
Session type:
Oral Presentation
Number:
4219
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ott, M. Allewelt, G. Korfmann, A. Kureishi, J. Lorenz, H. Lode (Berlin, Wuppertal, Luedenscheid, Germany). A novel approach in the treatment of aspiration pneumonia and primary lung abscess. Eur Respir J 2005; 26: Suppl. 49, 4219
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
A patient with intractable pneumonia
Source: Annual Congress 2006 - Interventional Pulmonology Grand Round: an interactive session
Year: 2006
Empyema treatment: about drains, fibrinolytics and when to call the surgeon
Source: Annual Congress 2007 - PG16 - Management of pleural problems in your practice today
Year: 2007
Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients
Source: Eur Respir J 2003; 22: 77S-83S
Year: 2003
Non-antibiotic treatment for severe pneumonia?
Source: Annual Congress 2005 - Outcome in severe pneumonia
Year: 2005
Are corticosteroids useful in community-acquired pneumonia?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006
Prophylactic antibiotics will affect the occurrence of post-bronchoscopic fever and pneumonia in patient with endobronchial obstructive lesions?
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007
Appropriateness and delay to initiate therapy in ventilator-associated pneumonia
Source: Eur Respir J 2006; 27: 158-164
Year: 2006
Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 20: 1213-1219
Year: 2002
Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia
Source: Eur Respir J 2002; 19: 944-951
Year: 2002
Pneumonia in children, pleural infection, necrotising pneumonia and lung abscess
Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019
Year: 2019
Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 45-49
Year: 2007
Necrotising pneumonia is an increasingly detected complication of pneumonia in children
Source: Eur Respir J 2008; 31: 1285-1291
Year: 2008
A case of recurrent right lower lobe pneumonia
Source: Annual Congress 2005 - Oncology Grand Round: an interactive session
Year: 2005
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011
Diagnostic importance of bronchial aspiration with protected catheter in COPD patients with unresolved community-acquired pneumonia (CAP)
Source: Eur Respir J 2001; 18: Suppl. 33, 541s
Year: 2001
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Source: Eur Respir J 2009; 33: 153-159
Year: 2009
The approach to antibiotic treatment in community-acquired pneumonia
Source: Annual Congress 2008 - MP14 - The approach to antibiotic treatment in community-acquired pneumonia
Year: 2008
Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis
Source: Eur Respir J 2011; 37: 858-864
Year: 2011
Pneumococcal pneumonia: an old disease with radically-new approaches for antibiotic therapy
Source: Annual Congress 2005 - Outcome in severe pneumonia
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept